Anti-tumor efficacy of hyaluronan-based nanoparticles for the co-delivery of drugs in lung cancerVictor Jeannot, Amandine Hurbin|Journal of Controlled Release|2018Cited by 88
The PI3K/AKT pathway promotes gefitinib resistance in mutant <i>KRAS</i> lung adenocarcinoma by a deacetylase‐dependent mechanismVictor Jeannot, Amandine Hurbin|International Journal of Cancer|2013Cited by 57
Synergistic activity of vorinostat combined with gefitinib but not with sorafenib in mutant KRAS human non-small cell lung cancers and hepatocarcinomaVictor Jeannot, Amandine Hurbin|OncoTargets and Therapy|2016Cited by 36
The pyrrolopyrimidine colchicine-binding site agent PP-13 reduces the metastatic dissemination of invasive cancer cells in vitro and in vivoPauline Gilson, Amandine Hurbin|Biochemical Pharmacology|2018Cited by 17